dc.creatorLopes L.F.
dc.creatorNeto E.D.
dc.creatorLorand-Metze I.
dc.creatorLatorre M.D.R.D.O.
dc.creatorSimpson A.J.G.
dc.date2001
dc.date2015-06-26T14:43:25Z
dc.date2015-11-26T14:16:35Z
dc.date2015-06-26T14:43:25Z
dc.date2015-11-26T14:16:35Z
dc.date.accessioned2018-03-28T21:17:35Z
dc.date.available2018-03-28T21:17:35Z
dc.identifier
dc.identifierBritish Journal Of Haematology. , v. 113, n. 4, p. 1001 - 1008, 2001.
dc.identifier71048
dc.identifier10.1046/j.1365-2141.2001.02826.x
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-0034937435&partnerID=40&md5=7f5ba56b6f22de9254060ebe8ffe12e9
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/95056
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/95056
dc.identifier2-s2.0-0034937435
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1243102
dc.descriptionThe frequency of the hybrid Vγ/Jβ trans-rearrangement in peripheral blood lymphocytes (PBLs) was analysed in a transversal study of paediatric patients (n = 210) with acute lymphoblastic leukaemia (ALL) and solid tumours (ST). Different amounts of DNA were used as the template for a nested polymerase chain reaction to evaluate the frequency of hybrid Vγ/Jβ genes, using silver-stained gels. The frequency of the rearrangement was evaluated in groups before, during and after therapy. A greatly increased frequency of Vγ/Jβ trans-rearrangement was found in PBLs of both groups of patients during exposure to chemotherapeutic agents compared with patients before chemotherapy. In patients who had finished treatment, the frequency of the rearrangement fell promptly to the baseline levels in ST but showed a slow decrease in ALL in those in whom increased levels could be found until 4 years after the end of treatment, We hypothesize that the chemotherapeutic agents are able to induce the Vγ/Jβ trans-rearrangement, but this is transient in most cases. The exact relationship between the persistence of the rearrangement and the occurrence of secondary leukaemia remains to be determined.
dc.description113
dc.description4
dc.description1001
dc.description1008
dc.descriptionAbdallah, J.M., Lombardi, D.P., Kirsch, I.R., Genetic instability in patients with Hodgkin's disease undergoing chemotherapy (1995) Journal of Clinical Investigations, 96, pp. 2744-2747
dc.descriptionBegley, C.G., Aplan, P.D., Davey, M.P., Nakahara, K., Tchorz, K., Kurtzberg, J., Hershfield, M., Kirsch, I.R., Chromosomal translocation in a human leukemic stem-cell line disrupts the T cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript (1989) Proceedings of the National Academy of Sciences of the United States of America, 86, pp. 2031-2035
dc.descriptionBerger, N.A., Chatterjee, S., Schmotzer, J.A., Helms, S.R., Etoposide (VP-16-213)-induced gene alterations: Potential contribution to cell death (1991) Proceedings of the National Academy of Sciences of the United States of America, 33, pp. 8740-8743
dc.descriptionBlin, N., Stafford, D.W., A general method for isolation of high molecular weght DNA from eukaryotes (1976) Nucleic Acids Research, 3, pp. 2303-2308
dc.descriptionBoder, E., Ataxia-telangiectasia: An overview (1985) Genetics, Neuropathology & Immunology of a Degenerative Disease of Childhood, pp. 1-63. , (ed, by R.A. Gatti & M. Swift), Alan Liss, New York
dc.descriptionBoyum, A., Isolation of molecular cells and granulocytes from human blood. Isolation of molecular cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1g (1968) Scandinavian Journal of Clinical Laboratory and Investigations Supplement, 97, pp. 77-89
dc.descriptionBrandallse, S., Odone, V., Pereira, W., Andrea, M., Zanichelli, M., Aranega, V., Treatment results of three consecutive Brazilian cooperative childhood ALL protocolos, GBTLI-80, GBTLI-82 and -85 (1993) Leukemia, 7, pp. S142-S145
dc.descriptionCanellos, G.P., Anderson, J.R., Propert, K.J., Nissen, N., Cooper, M.R., Henderson, E.S., Green, M.R., Peterson, B.A., Chemotherapy of advanced Hodgkin's disease with MOPP. ABVD, or MOPP alternating with ABVD (1992) New England Journal of Medicine, 327, pp. 1478-1484
dc.descriptionChambers, S.K., Chopyk, R.L., Chambers, J.T., Schwartz, P.E., Duffy, T.P., Development of leukemia after doxorubicin and cisplatin treatment of ovarian cancer (1989) Cancer, 64, pp. 2459-2461
dc.descriptionChen, C.L., Fuscoe, J.C., Liu, Q., Relling, M.V., Etoposide causes illegitimate V (D) J recombination in human lymphoid leukemic cells (1996) Blood, 88, pp. 2210-2218
dc.descriptionDavodeau, F., Peyrat, M.A., Gaschet, J., Hallet, M.M., Triebel, F., Vie, H., Kabelitz, K., Bonneville, M., Surface expression of functional T-cell receptor chains formed by interlocus recombinations on human T-lymphocytes (1994) Journal of Experimental Medicine, 180, pp. 1685-1691
dc.descriptionDe Benedetti, V., Bennett, W.P., Greenblatt, M.S., Harris, C.C., p53 Tumor suppressor gene: Implications for iatrogenic cancer and cancer therapy (1996) Medicine Pediatrics Oncology, 27, pp. 2-11
dc.descriptionFuscoe, J.C., Setzer, R.W., Collard, D.D., Moore, M.M., Quantification of T (14: 18) in the lymphocytes of healthy adult humans as a possible biomarker for enviromental exposures to carcinogens (1996) Carcinogenesis, 17, pp. 1013-1020
dc.descriptionFuscoe, J.C., Vira, L.K., Collard, D.D., Moore, M.M., Quantification of hprt gene deletions mediated by ilegitimate V (D) J recombination in peripheral blood cells of humans (1997) Environmental Molecular Mutagen, 29, pp. 28-35
dc.descriptionFuscoe, J.C., Knapp, G.W., Hanley, N.M., Setzer, R.W., Sandlund, J.T., Pui, C.H., Relling, M.V., The frequency of illegitimate V (D) J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy (1998) Mutation Research, 419, pp. 107-121
dc.descriptionGriesser, H., Tkachuk, D., Reis, M.D., Mak, T.W., Gene rearrangements and translocations in lymphoprollferative diseases (1989) Blood, 73, pp. 1402-1415
dc.descriptionHan, Y.H., Austin, M.J., Pommier, Y., Povirk, L.F., Small deletion and insertion mutations induced by the topoisomerase II innhibitor teniposide in CHO cells and comparison with sites of frug-stimulated DNA cleavage in vitro (1993) Journal of Molecular Biology, 220, pp. 52-66
dc.descriptionHudson, M.M., Donaldson, S.S., Treatment of pediatric Hodgldn's Lymphoma (1999) Seminars in Hematology, 36, pp. 313-323
dc.descriptionJeha, S., Jaffe, N., Robertson, R., Secondary acute non-Lymphoblastic Leukemia in two children following treatment with a Cis-Diamminedichloroplatinum-II-based regimen for osteossarcoma (1992) Medicine Pediatrics Oncology, 20, pp. 71-74
dc.descriptionKarnaoukhova, L., Moffat, J., Martins, H., Glickman, B., Mutation frequency and spectrum in lymphocytes of samll cell lung cancer patients receiving etoposide chemotherapy (1997) Cancer Research, 57, pp. 4393-4407
dc.descriptionKirsch, I.R., Lipkowitz, S.A., A mesure of genomic instability and its relevance to lymphomageneis (1992) Cancer Research, 52, pp. 5545s-5546s
dc.descriptionLevine, E.G., Bloomfield, C.D., Leukemias and myelodysplastic syndromes secondary to drug, radiation and environmental exposure (1992) Seminars in Oncology, 19, pp. 47-84
dc.descriptionLipkowitz, S., Stern, M.H., Kirsch, I.R., Hybrid T-cell receptor genes formed by interlocus recombination in normal and ataxia-teleangiectasia lymphocytes (1990) Journal of Experimental Medicine, 172, pp. 409-418
dc.descriptionLipkowitz, S., Garry, V.F., Kirsch, I.R., Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies (1992) Proceedings of the National Academy of Sciences of the United States of America, 89, pp. 5301-5305
dc.descriptionMeydan, D., Nilsson, T., Törnblom, M., Hagmar, L., Hellgren, D., Fuscoe, J.C., Lambert, B., The frequency of illegitimate TCRβ/γ gene recombination in human lymphocytes: Influence of age, enviromental exposure and cytostatic treatment, and correlation with frequencies of T (14
dc.description18) and hprt mutation (1999) Mutation Research, 444, pp. 393-403
dc.descriptionNichols, C.R., Breeden, E.S., Loeherer, Pj., Willians, S.D., Einhorn, L.H., Secondary leukemia associated with a conventional dose of etoposide. Review of serial germ cell tumor protocols (1993) Journal of the National Cancer Institute, 85, pp. 36-40
dc.descriptionPedersen-Bjergaard, J., Daugaard, G., Hansen, S.W., Philip, P., Larsen, S.O., Rorth, M., Increased risk of myelodysplasia and leukemia after etoposide, cisplatin and bleomycin for germ-cell tumors (1991) Lancet, 338, pp. 359-363
dc.descriptionPui, C.H., Ribeiro, R., Hancock, M.L., Rivera, G.K., Evans, W.E., Raimondi, S., Head, D.R., Crist, W., Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphocytic leukemia (1991) New England Journal of Medicine, 325, pp. 1682-1687
dc.descriptionRabbits, T.H., Chromosomal translocations in human cancer (1994) Nature, 372, pp. 143-149
dc.descriptionRatain, M.J., Kaminer, L.S., Bitran, J.D., Larson, R.A., LeBeau, M.M., Skosey, C., Purl, S., Golomb, H.M., Acute nonlymphocytic leukemia following Etoposide and cisplatin combination chemotherapy for advanced non small cell carcinoma of the lung (1987) Blood, 70, pp. 1412-1417
dc.descriptionReed, E., Yuspa, S.H., Zwelling, L.A., Ozols, R.F., Poirier, M.C., Quantification of cis-Diamminedichloroplatinum II (cisplatin)-DNA-intrastand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy (1996) Journal of Clinical Investigations, 77, pp. 545-550
dc.descriptionReiter, A., Schrappe, M., Ludwig, W., Hiddemann, W., Sauter, S., Henze, G., Zimmermann, M., Riehm, H., Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM'86 (1994) Blood, 84, pp. 3122-3133
dc.descriptionSanguinetti, C.J., Dias Neto, E., Simpson, A.J.G., Rapid silver staining and recovery of PCR products separated on polyacrylamide gels (1994) Biotechniques, 17, pp. 915-918
dc.descriptionSmith, M.A., Rubinstein, L., Ungerleider, R.S., Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risks (1994) Medicine Pediatrics Oncology, 23, pp. 86-98
dc.descriptionTates, A.D., Van Dam, F.J., Natarajan, A.T., Zwinderman, A.H., Osanto, S., Frequencies of HPRT mutants and micronuclei in lymphocytes of cancer patients under chemotherapy: A prospective study (1994) Mutation Research, 307, pp. 293-307
dc.descriptionTewey, K.M., Rowe, T.C., Yang, L., Halligan, B.D., Liu, L.F., Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II (1984) Science, 226, pp. 466-468
dc.descriptionTucker, M.A., Meadows, A.T., Boice, J.D., Stovall, M., Oberlin, O., Stone, B.J., Birch, J., Fraumeni J.F., Jr., Leukemia after therapy with alkylating agents for childhood cancer (1987) Journal of the National Cancer Institute, 78, pp. 459-464
dc.descriptionVan Leeuwen, F.E., Klokman, W.J., Hagenbeek Noyon, R., Van Den Belt-Dusebout, A.W., Van Kerkhoff, E.H., Van Heerde, P., Somers, R., Second cancer risk following Hodgkin's disease: A 20-year follow-up study (1994) Journal of Clinical Oncology, 12, pp. 312-325
dc.descriptionVan Leeuwen, F.E., Klokman, W.J., Van't Veer, M.B., Hagenbeek, A., Krol, A.D.G., Vetter, U.A.O., Schaapveld, M., Aleman, B.M.P., Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood (2000) Journal of Clinical Oncology, 18, pp. 487-497
dc.descriptionWaldmann, T.A., The arrangement of immunoglobulin and T cell receptor genes in human lymphoproliferative disorders (1987) Advances in Immunology, 40, pp. 247-231
dc.descriptionWolden, S.L., Lambron, K.R., Cleary, S.F., Tate, D.J., Donaldson, S.S., Second cancers following pediatric Hodgkin's disease (1998) Journal of Clinical Oncology, 16, pp. 536-544
dc.languageen
dc.publisher
dc.relationBritish Journal of Haematology
dc.rightsfechado
dc.sourceScopus
dc.titleAnalysis Of Vγ/jβ Trans-rearrangements In Paediatric Patients Undergoing Chemotherapy
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución